Accordingly, examination of public functional genomics data revealed that the Runx1-bound Zeb1 enhancer we identified in mK4 cells is accessible (i.e., DNase hypersensitive) in other tissues including several hemopoietic cell lines (S4 Table) and is also bound by Runx1 in AML. This evidence concerns the gene ZEB1 and acute myeloid leukemia.